Stadler, N., Hasibeder, A., Lopez, P. A., Teschner, D., Desuki, A., Kriege, O., Weber, A. N. R., Schulz, C., Michel, C., HeβG. and Radsak, M. P. (2017) “The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation”, Haematologica. Pavia, Italy, 102(5), pp. e191-e194. doi: 10.3324/haematol.2016.152017.